Mauricio Oyarzo

598 citations
14 papers · 419 indexed · h-index 10
Topics
Lymphoma Diagnosis and Treatment (6 papers)Chronic Myeloid Leukemia Treatments (3 papers)Acute Myeloid Leukemia Research (2 papers)
Partner nations
United StatesChileSweden

In The Last Decade

Mauricio Oyarzo

14 papers receiving 412 citations

Peers

Mauricio Oyarzo
Comparison fields: 5 of 68
  • Molecular Biology 190
  • Hematology 122
  • Oncology 101
  • Pulmonary and Respiratory Medicine 95
  • Surgery 74
Replace Maide Cavalli with:
Maide Cavalli Italy
Ji Xu China
Yiqun Zhang China
Stephen Wu United States
Thamar van Dijk Netherlands
Victor Yazbeck United States
Yuqin Song China
Wenda Ye United States
Amalia Milano Italy
Takayuki Ninomiya Japan
Mauricio Oyarzo relative to Maide Cavalli Italy Maide Cavalli's profile →
Citations per field
00.5×4.8×
Maide Cavalli · 1×
Citations per year

Countries citing papers authored by Mauricio Oyarzo

Since Specialization
Citations

This map shows the geographic impact of Mauricio Oyarzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauricio Oyarzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauricio Oyarzo more than expected).

Fields of papers citing papers by Mauricio Oyarzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauricio Oyarzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauricio Oyarzo. The network helps show where Mauricio Oyarzo may publish in the future.

Co-authorship network of co-authors of Mauricio Oyarzo

This figure shows the co-authorship network connecting the top 25 collaborators of Mauricio Oyarzo. A scholar is included among the top collaborators of Mauricio Oyarzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauricio Oyarzo. Mauricio Oyarzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 36
2 64
3 6
4 9
5 30
6 7
7 33
8 83
9 20
10 57
11 51
12 4
13 8
14 11

About Mauricio Oyarzo

Mauricio Oyarzo is a scholar working on Hematology, Process Chemistry and Technology and Pathology and Forensic Medicine, having authored 14 papers that have together received 419 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Hematology (122 citations), Gastroenterology (29 citations) and Genetics (54 citations). Mauricio Oyarzo has collaborated with scholars based in United States, Chile and Sweden. Frequent co-authors include L. Jeffrey Medeiros, George Z. Rassidakis, Carlos E. Bueso-Ramos, Armand B. Glassman, Rajyalakshmi Luthra, Hesham M. Amin, Kurt A. Schalper, Daniel Carvajal‐Hausdorf, Pei Lin and Preetha Ramalingam. Their work appears in journals such as Blood, Cancer and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026